Publikationen in Zusammenarbeit mit Forschern von Charité (59)

2023

  1. EAACI guidelines on the diagnosis of IgE-mediated food allergy

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 12, pp. 3057-3076

  2. Erratum : World Allergy Organization Anaphylaxis Guidance 2020 [Japanese Journal of Allergology Vol.70 (2021) No.9 p.1211-1234]

    Arerugi = [Allergy], Vol. 72, Núm. 3, pp. 314

  3. Food-Induced Anaphylaxis: Data From the European Anaphylaxis Registry

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 7, pp. 2069-2079.e7

  4. Omalizumab in IgE-Mediated Food Allergy: A Systematic Review and Meta-Analysis

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 4, pp. 1134-1146

2022

  1. Allergen immunotherapy and/or biologicals for IgE-mediated food allergy: A systematic review and meta-analysis

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 6, pp. 1852-1862

  2. Development and validation of the food allergy severity score

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 5, pp. 1545-1558

  3. EAACI guidelines: Anaphylaxis (2021 update)

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 2, pp. 357-377

  4. Improving the reporting of allergic adverse events during immunotherapy for food allergy

    Journal of Allergy and Clinical Immunology

  5. Managing food allergy: GA2LEN guideline 2022

    World Allergy Organization Journal, Vol. 15, Núm. 9

  6. Open-label follow-on study evaluating the efficacy, safety, and quality of life with extended daily oral immunotherapy in children with peanut allergy

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 3, pp. 991-1003

  7. Participant characteristics and safety outcomes of peanut oral immunotherapy in the RAMSES and ARC011 trials

    Annals of Allergy, Asthma and Immunology, Vol. 129, Núm. 6, pp. 758-768.e4

  8. Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food—A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 6, pp. 1736-1750

2021

  1. Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 9, Núm. 5, pp. 1879-1889.e14

  2. Diagnosing, managing and preventing anaphylaxis: Systematic review

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 5, pp. 1493-1506

  3. Phenotype and risk factors of venom-induced anaphylaxis: A case-control study of the European Anaphylaxis Registry

    Journal of Allergy and Clinical Immunology, Vol. 147, Núm. 2, pp. 653-662.e9

  4. Prevalence and early-life risk factors of school-age allergic multimorbidity: The EuroPrevall-iFAAM birth cohort

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 9, pp. 2855-2865

  5. Primary and pollen-associated hazelnut allergy in school-aged children in Germany: A birth cohort study

    Allergology International, Vol. 70, Núm. 4, pp. 463-470

  6. World Allergy Organization Anaphylaxis Guidance 2020

    Arerugi = [Allergy], Vol. 70, Núm. 9, pp. 1211-1234

2020

  1. EAACI anaphylaxis guidelines: Systematic review protocol

    Clinical and Translational Allergy

  2. Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial

    The Lancet Child and Adolescent Health, Vol. 4, Núm. 10, pp. 728-739